Market Trends Toward New Normal - NASDAQ OMX GlobeNewswire

NEW YORK, Aug. 31, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Caesars Entertainment Corporation (NASDAQ: CZR ), Nektar Therapeutics (NASDAQ: NKTR ), Boston Scientific Corporation (NYSE: BSX ), Apollo Commercial Real Estate Finance (NYSE: ARI ), Kellogg Company (NYSE: K ), and Foot Locker, Inc. (NYSE: FL ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CZR DOWNLOAD: http://Fundamental-Markets.com/register/?so=CZR NKTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=NKTR BSX DOWNLOAD: http://Fundamental-Markets.com/register/?so=BSX ARI DOWNLOAD: http://Fundamental-Markets.com/register/?so=ARI K DOWNLOAD: http://Fundamental-Markets.com/register/?so=K FL DOWNLOAD: http://Fundamental-Markets.com/register/?so=FL

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Caesars Entertainment Corporation (NASDAQ: CZR ), Nektar Therapeutics (NASDAQ: NKTR ), Boston Scientific Corporation (NYSE: BSX ), Apollo Commercial Real Estate Finance (NYSE: ARI ), Kellogg Company (NYSE: K ), and Foot Locker, Inc. (NYSE: FL ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 29th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CAESARS ENTERTAINMENT CORPORATION (CZR) REPORT OVERVIEW

Caesars Entertainment's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Caesars Entertainment reported revenue of $2,119.00MM vs $1,008.00MM (up 110.22%) and basic earnings per share $0.04 vs -$9.62. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Caesars Entertainment reported revenue of $4,852.00MM vs $3,877.00MM (up 25.15%) and basic earnings per share -$1.35 vs -$20.85. Caesars Entertainment is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.19. The estimated EPS forecast for the next fiscal year is $0.12 and is expected to report on March 6th, 2019.

To read the full Caesars Entertainment Corporation (CZR) report, download it here: http://Fundamental-Markets.com/register/?so=CZR

-----------------------------------------

NEKTAR THERAPEUTICS (NKTR) REPORT OVERVIEW

Nektar Therapeutics' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Nektar Therapeutics reported revenue of $1,087.72MM vs $34.59MM (up 3,044.69%) and basic earnings per share $5.67 vs -$0.39. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Nektar Therapeutics reported revenue of $307.71MM vs $165.44MM (up 86.00%) and basic earnings per share -$0.62 vs -$1.10. Nektar Therapeutics is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.37. The estimated EPS forecast for the next fiscal year is -$1.13 and is expected to report on March 7th, 2019.

To read the full Nektar Therapeutics (NKTR) report, download it here: http://Fundamental-Markets.com/register/?so=NKTR

-----------------------------------------

BOSTON SCIENTIFIC CORPORATION (BSX) REPORT OVERVIEW

Boston Scientific's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Boston Scientific reported revenue of $2,490.00MM vs $2,257.00MM (up 10.32%) and basic earnings per share $0.40 vs $0.11 (up 263.64%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Boston Scientific reported revenue of $9,048.00MM vs $8,386.00MM (up 7.89%) and basic earnings per share $0.08 vs $0.26 (down 69.23%). Boston Scientific is expected to report earnings on October 25th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.31. The estimated EPS forecast for the next fiscal year is $1.58 and is expected to report on February 7th, 2019.

To read the full Boston Scientific Corporation (BSX) report, download it here: http://Fundamental-Markets.com/register/?so=BSX

-----------------------------------------

APOLLO COMMERCIAL REAL ESTATE FINANCE (ARI) REPORT OVERVIEW

Apollo Commercial Real Estate Finance's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Apollo Commercial Real Estate Finance reported revenue of $70.78MM vs $62.22MM (up 13.75%) and basic earnings per share $0.39 vs $0.28 (up 39.29%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Apollo Commercial Real Estate Finance reported revenue of $260.46MM vs $200.62MM (up 29.83%) and basic earnings per share $1.54 vs $1.74 (down 11.49%). Apollo Commercial Real Estate Finance is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.54. The estimated EPS forecast for the next fiscal year is $1.95 and is expected to report on February 13th, 2019.

To read the full Apollo Commercial Real Estate Finance (ARI) report, download it here: http://Fundamental-Markets.com/register/?so=ARI

-----------------------------------------

KELLOGG COMPANY (K) REPORT OVERVIEW

Kellogg's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Kellogg reported revenue of $3,360.00MM vs $3,175.00MM (up 5.83%) and basic earnings per share $1.72 vs $0.81 (up 112.35%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Kellogg reported revenue of $12,923.00MM vs $13,014.00MM (down 0.70%) and basic earnings per share $3.65 vs $1.98 (up 84.34%). Kellogg is expected to report earnings on October 30th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $1.05. The estimated EPS forecast for the next fiscal year is $4.73 and is expected to report on February 14th, 2019.

To read the full Kellogg Company (K) report, download it here: http://Fundamental-Markets.com/register/?so=K

-----------------------------------------

FOOT LOCKER, INC. (FL) REPORT OVERVIEW

Foot Locker's Recent Financial Performance

For the three months ended April 30th, 2018 vs April 30th, 2017, Foot Locker reported revenue of $2,025.00MM vs $2,001.00MM (up 1.20%) and basic earnings per share $1.39 vs $1.37 (up 1.46%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Foot Locker reported revenue of $7,782.00MM vs $7,766.00MM (up 0.21%) and basic earnings per share $2.23 vs $4.95 (down 54.95%). Foot Locker is expected to report earnings on November 16th, 2018. The report will be for the fiscal period ending October 31st, 2018. The reported EPS for the same quarter last year was $0.87. The estimated EPS forecast for the next fiscal year is $4.79 and is expected to report on March 1st, 2019.

To read the full Foot Locker, Inc. (FL) report, download it here: http://Fundamental-Markets.com/register/?so=FL

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.